AUG 17, 2026 · PHASE 1 TRIAL
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
ClinicalTrials.gov
This is a Phase 1 trial registration with no reported results; the study is actively recruiting and designed to evaluate safety, tolerability, and preliminary antitumor activity in an early-stage drug development program.
Reported
PhasePhase 1
Estimated enrollment738
Primary outcome measure (dose esc…Dose-limiting toxicity (DLT) at end of Cycl…